PATEL v. ZOOMPASS HOLDINGS, INC. et al, No. 2:2017cv03831 - Document 18 (D.N.J. 2017)

Court Description: OPINION AND ORDER granting 3 Motion to Appoint Lead Plaintiff ; granting 3 Motion to Appoint Counsel ; denying 4 Motion to Appoint Lead Plaintiff. ; denying 6 Motion to Appoint Lead Plaintiff.. Signed by Chief Judge Jose L. Linares on 9/20/17. (sr, )

Download PDF

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY Plaintiff, Civil Action No.: 17-3831 (JLL) OPINION V. ZOOMPASS HOLDINGS INC., Defendants. IT APPEARING THAT: 1. Currently pending before the court are three motions to appoint lead plaintiff and lead counsel made pursuant to the Private Securities Litigation Refonn Act of 1995 (“PSLRA”). 2. On July 31, 2017, Plaintiff Carlos Guillenno Julian Vega (“Vega”) moved to have himself appointed lead plaintiff and his attorneys at the law finTi of Wolf Haldenstein Adler freeman & Hertz (“Wolf Haldenstein”) appointed as lead counsel. (ECF No. 3). On the same date, Plaintiff Robert Davis (“Davis”) moved to be appointed lead plaintiff and his attorneys at the law firm of Glancy Prongay & Murray LLP appointed as lead counsel with Carella, Byrne, Cecchi, Olstein, Brody & Agnello. P.C. as liaison counsel. (ECF No. 4). Additionally, at that time Henry C. Reusch, Cheryl D. Puccio, Mihaita Virjoghe collectively as the Zoompass Investor Group (“Zoompass Investor Group”) moved to be appointed lead plaintiffs and have their attorneys at the law firm of Pomerantz and Rosen as co-lead counsel and Lite DePalma as liaison counsel. (ECF No. 6). Dockets.Justia.com PATEL ET AL. 3. Under the PSLRA, this Court shall appoint the class member who is most capable of adequately representing the interests of class members as lead plaintiff See 15 U.S.C. § 7$u- 4(a)(3)(B). In order to determine the “most adequate” plaintiff, this Court must consider two questions: (1) which plaintiff has the largest financial interest in the relief sought by the class and (ii) which plaintiff otherwise satisfies the requirements of Rule 23 of the Federal Rules of Civil Procedure. See 15 U.S.C. § 78u-4(a)(3)(B)(iii). 4. As for the first question, courts should consider (1) the number of shares that the movant purchased during the putative class period; (2) the total net funds expended by the plaintiffs during the class period; and (3) the approximate losses suffered by the plaintiffs. In re Cendant Corp. Litig., 264 F.3d 201, 262 (3d Cir. 2001) (citing Lax v. first Merchants Acceptance Corp., No. 97 C 2716, 1997 U.S. Dist. LEXIS 11866, at *18 (N.D. Ill. Aug. 6, 1997)). The most critical among these factors is the approximate loss suffered. See, e.g., In re Vicuron Pharms., Inc. Sec. Litig., 225 F.R.D. 508, 511 (E.D. Pa. 2004); Janovici v. DVI, Inc., No. 03-4795, 2003 U.S. Dist. LEXIS 22315, at *39 (E.D.Pa. Nov. 25, 2003); In reAm. Bits. fin. Sen’s., Inc. Sec. Litig., 2004 U.S. Dist. LEXIS 10200, at *23 (E.D. Pa. Jun. 3, 2004); A.F.I.K. Holding SPRL v. fass, 216 F.R.D. 567, 572 (D. N.J. 2003). 5. For the second question, Rule 23(a) generally provides that a class action may proceed if the following four requirements are satisfied: (1) the class is so numerous that joinder of all members is impracticable, (2) there are questions of law or fact common to the class, (3) the claims or defenses of the representative parties are typical of the claims or defenses of the class, and (4) the representative parties will fairly and adequately protect the interests of the class. Generally, only typicality of claims and adequacy of representation are relevant for the determination of lead plaintiff under the PSLRA. See In re Oxford Health Plans, Inc. Sec. Litig., 182 F.R.D. 42, 49 2 (S.D.N.Y. 199$) (citing Gluck v. Cd/star Corp., 976 F. Supp. 542, 546 (N.D. Tex. 1997) and Fischlerv. Amsoitth Bancorporation, 176 F.R.D. 583 (M.D. Fla. 1997)). 6. As for the detenuination of lead counsel, the PSLRA vests authority in the lead plaintiff to select and retain counsel, subject only to approval of the Court. See 15 U.S.C. §78u-4(a)(3)(B)(v). The Court should not disturb the plaintiffs choice unless the Court finds it necessary to protect the interests of the class. See 15 U.S.C. §7$u-4(a)(3)(B)(iii)(II)(aa). 7. All Plaintiffs here have the same claims and otherwise meet the requirements of Rule 23, and so the second question is not in dispute for any of the three motions. (ECF Nos. 3 at 6—8 (arguing plaintiff meets requirements of Rule 23); 4 at 5—6 (same); 6 at 5—8 (same)). Therefore, the determination of lead plaintiff turns on which of the three Plaintiffs has the largest financial interest. 8. The Court finds, out of the three motions, Plaintiff Vega has alleged the largest financial interest under any factor, but most notably his approximate loss is $139,815 in comparison to Davis’s loss of $24,935 and the Zoompass Investor Group’s loss of $95,233. (ECF No. 13 at 2). Therefore, Plaintiff Vega is the most adequate lead plaintiff. 9. Furthermore, Plaintiff Vega has provided ample indication that Wolf Haldenstein has the experience to serve as lead counsel. (ECF No. 3 at 8—9, 3—4). Therefore, the Court approves Wolf Haldenstein as lead counsel. For these reasons, 3 _____ IT IS THEREFORE on this day of September, 2017, ORDERED that Plaintiff Carlos Guillenno Julian Vega’s motion to be appointed lead plaintiff (ECF No. 3) is hereby GRANTED; and it is further ORDERED that Plaintiff Carlos Guillermo Julian Vega’s motion to grant Wolf Haldenstein Adler Freeman & Hertz as lead counsel (ECF No. 3) is hereby GRANTED; and it is further ORDERED that Plaintiff Robert Davis’s motion to be appointed lead plaintiff and to appoint lead counsel (ECF No. 4) is hereby DENIED; and it is further ORDERED that Plaintiffs Zoompass Investor Group’s motion to be appointed lead plaintiffs and to appoint lead counsel (ECF No. 6) is hereby DENIED. SO ORDERED. JØE L. LINAR S ,,‘hief Judge, United States District Court 4

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.